Learning Objectives                                                                                                                                                         At the conclusion of this activity, participants will be able to:

• Explain the emerging role of chimeric antigen receptor (CAR) T-cell treatment as an option for patients with relapsed/refractory blood cancer

• Discuss treatment plans for patient care

• Explain potential short- and long-term side effects and management

• Identify patients who could potentially be treated with CAR therapy

• Engage patients and caregivers in discussions on CAR T-cell therapies including benefits, risks, and barriers to entry 

Target Audience                                                                                                                                                          Hematologists-oncologists, medical oncologists, oncology fellows, pharmacists, physician assistants, nurse practitioners, nurses, and oncology social workers at the intermediate and advanced level involved in the care of patients with hematologic malignancies.   

Questions/Grievances

For questions, grievances, or assistance with special needs (physical, dietary, etc.) please contact us prior to the program at (914) 821-8420 or email caroline.kornhauser@lls.org. 

Providers                                                                                                                                                                               This activity is jointly provided by The Leukemia & Lymphoma Society & Medical Learning Institute, Inc. 

Supporters                                                                                                                                                                           This activity is supported by educational grants from Celgene Corporation, and Kite, a Gilead Company.  

Continuing Education Information (See additional Tab)                                                                                            There is no fee for this educational activity. To receive credit for this CME/CPE/CE activity, complete the  preassessment, course, post- assessment, and evaluation and return it to the on-site coordinator. Your certificate of  credit will be e-mailed to you within 4 weeks. For  pharmacists, MLI will accept your completed evaluation form for up to 30 days and will report your participation to the NABP only if you  provide your NABP e-Profile number and  date of birth. Within 6 weeks, view your participation record at the NABP website: mycpemonitor.net.